HealthEquity Research Development from 2010 to 2026
| HQY Stock | USD 73.88 0.67 0.92% |
Research Development | First Reported 2012-04-30 | Previous Quarter 64.8 M | Current Value 65.9 M | Quarterly Volatility 23.1 M |
Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 196.2 M, Interest Expense of 73.2 M or Selling General Administrative of 159.7 M, as well as many indicators such as Price To Sales Ratio of 6.55, Dividend Yield of 0.0735 or PTB Ratio of 5.59. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.
HealthEquity | Research Development | Build AI portfolio with HealthEquity Stock |
The evolution of Research Development for HealthEquity provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how HealthEquity compares to historical norms and industry peers.
Latest HealthEquity's Research Development Growth Pattern
Below is the plot of the Research Development of HealthEquity over the last few years. It is HealthEquity's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HealthEquity's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
HealthEquity Research Development Regression Statistics
| Arithmetic Mean | 100,475,229 | |
| Geometric Mean | 40,914,262 | |
| Coefficient Of Variation | 105.53 | |
| Mean Deviation | 93,552,623 | |
| Median | 35,057,000 | |
| Standard Deviation | 106,026,615 | |
| Sample Variance | 11241.6T | |
| Range | 285M | |
| R-Value | 0.94 | |
| Mean Square Error | 1385.2T | |
| R-Squared | 0.88 | |
| Slope | 19,746,422 | |
| Total Sum of Squares | 179866.3T |
HealthEquity Research Development History
About HealthEquity Financial Statements
HealthEquity investors use historical fundamental indicators, such as HealthEquity's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 275.4 M | 289.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.